Karyopharm Therapeutics Inc.
KPTINASDAQHealthcare● Active
$8.50
$-0.58(-6.39%)
Market Cap$192635016
P/E Ratio—
52W High$10.99
52W Low$3.65
Karyopharm Therapeutics Inc.（KPTI）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · KPTI · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.15B | $0.15B | $0.15B | $0.16B | $0.21B |
| Cost of Revenue | $0.01B | $0.01B | $0.00B | $0.01B | $0.00B |
| Gross Profit | $0.14B | $0.14B | $0.14B | $0.15B | $0.21B |
| Gross Margin %(computed) | 95.93% | 95.86% | 96.62% | 96.68% | 98.38% |
| Operating Expenses | |||||
| R&D Expenses | $0.13B | $0.14B | $0.14B | $0.15B | $0.16B |
| G&A Expenses | $0.11B | $0.12B | $0.13B | $0.15B | $0.14B |
| Total Operating Expenses | $0.23B | $0.26B | $0.27B | $0.29B | $0.30B |
| Operating Income | ($0.09B) | ($0.12B) | ($0.13B) | ($0.14B) | ($0.10B) |
| Operating Margin %(computed) | -62.10% | -82.24% | -88.71% | -90.53% | -46.84% |
| Interest Income | $0.00B | $0.01B | $0.01B | $0.00B | $0.00B |
| Interest Expense | $0.05B | $0.04B | $0.02B | $0.02B | $0.03B |
| Income Before Tax | ($0.20B) | ($0.08B) | ($0.14B) | ($0.16B) | ($0.12B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.20B) | ($0.08B) | ($0.14B) | ($0.17B) | ($0.12B) |
| Net Margin %(computed) | -134.21% | -52.62% | -97.99% | -105.23% | -59.14% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-17.93 | $-9.41 | $-18.79 | $-30.28 | $-24.75 |
| Wtd Avg Shares | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B |
| EBITDA | ($0.15B) | ($0.04B) | ($0.12B) | ($0.14B) | ($0.10B) |
| EBITDA Margin %(computed) | -102.59% | -26.58% | -81.09% | -88.69% | -46.22% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · B
深入了解Karyopharm Therapeutics Inc.
关于Karyopharm Therapeutics Inc.（KPTI）损益表
Karyopharm Therapeutics Inc.（KPTI）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，KPTI实现营收$0.15B，毛利润$0.14B（毛利率95.93%），净利润($0.20B)（净利率-134.21%）。
常见问题
KPTI · 4 问Karyopharm Therapeutics Inc.（KPTI）2025财年营收为$0.15B，同比up0.6%。
KPTI revenueKPTI salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09